201 related articles for article (PubMed ID: 26917736)
21. DDX41: exploring the roles of a versatile helicase.
Winstone L; Jung Y; Wu Y
Biochem Soc Trans; 2024 Feb; 52(1):395-405. PubMed ID: 38348889
[TBL] [Abstract][Full Text] [Related]
22. Ribosome profiling analysis reveals the roles of DDX41 in translational regulation.
Tungalag S; Shinriki S; Hirayama M; Nagamachi A; Kanai A; Inaba T; Matsui H
Int J Hematol; 2023 Jun; 117(6):876-888. PubMed ID: 36780110
[TBL] [Abstract][Full Text] [Related]
23. Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation.
Berger G; van den Berg E; Sikkema-Raddatz B; Abbott KM; Sinke RJ; Bungener LB; Mulder AB; Vellenga E
Leukemia; 2017 Feb; 31(2):520-522. PubMed ID: 27795557
[No Abstract] [Full Text] [Related]
24. Unique ethnic features of
Choi EJ; Cho YU; Hur EH; Jang S; Kim N; Park HS; Lee JH; Lee KH; Kim SH; Hwang SH; Seo EJ; Park CJ; Lee JH
Haematologica; 2022 Feb; 107(2):510-518. PubMed ID: 33626862
[TBL] [Abstract][Full Text] [Related]
25. Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations.
Qu S; Li B; Qin T; Xu Z; Pan L; Hu N; Huang G; Peter Gale R; Xiao Z
Br J Haematol; 2021 Mar; 192(6):1006-1010. PubMed ID: 32307695
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular correlates of somatic and germline
Badar T; Nanaa A; Foran JM; Viswanatha D; Al-Kali A; Lasho T; Finke C; Alkhateeb HB; He R; Gangat N; Shah M; Tefferi A; Mangaonkar AA; Litzow MR; Ongie LJ; Chlon T; Ferrer A; Patnaik MM
Haematologica; 2023 Nov; 108(11):3033-3043. PubMed ID: 37199125
[TBL] [Abstract][Full Text] [Related]
27. [Lenalidomide for myelodysplastic syndrome with excess blasts with germline DDX41 mutation: a case report and literatures review].
Chen J; Qu SQ; Qin TJ; Xiao ZJ; Xu ZF
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):857-860. PubMed ID: 33190445
[No Abstract] [Full Text] [Related]
28. Lifting the veil on germline DDX41 mutations.
Sanders MA
Blood; 2019 Oct; 134(17):1368-1370. PubMed ID: 31698430
[No Abstract] [Full Text] [Related]
29. Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms.
Alkhateeb HB; Nanaa A; Viswanatha D; Foran JM; Badar T; Sproat L; He R; Nguyen P; Jevremovic D; Salama ME; Greipp P; Gangat N; Tefferi A; Litzow MR; Mangaonkar AA; Shah MV; Patnaik M; Al-Kali A
Blood Adv; 2022 Jan; 6(2):528-532. PubMed ID: 34644397
[TBL] [Abstract][Full Text] [Related]
30. The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
Maierhofer A; Mehta N; Chisholm RA; Hutter S; Baer C; Nadarajah N; Pohlkamp C; Thompson ER; James PA; Kern W; Haferlach C; Meggendorfer M; Haferlach T; Blombery P
Blood Adv; 2023 Dec; 7(23):7346-7357. PubMed ID: 37874914
[TBL] [Abstract][Full Text] [Related]
31. Insights into the Involvement of Spliceosomal Mutations in Myelodysplastic Disorders from Analysis of SACY-1/DDX41 in
Tsukamoto T; Gearhart MD; Kim S; Mekonnen G; Spike CA; Greenstein D
Genetics; 2020 Apr; 214(4):869-893. PubMed ID: 32060018
[TBL] [Abstract][Full Text] [Related]
32. Germline Predisposition to Hematolymphoid Neoplasia.
Weinberg OK; Kuo F; Calvo KR
Am J Clin Pathol; 2019 Aug; 152(3):258-276. PubMed ID: 31309983
[TBL] [Abstract][Full Text] [Related]
33. Novel DDX41 variants in Thai patients with myeloid neoplasms.
Polprasert C; Takeda J; Niparuck P; Rattanathammethee T; Pirunsarn A; Suksusut A; Kobbuaklee S; Wudhikarn K; Lawasut P; Kongkiatkamon S; Chuncharunee S; Songserm K; Phowthongkum P; Bunworasate U; Nannya Y; Yoshida K; Makishima H; Ogawa S; Rojnuckarin P
Int J Hematol; 2020 Feb; 111(2):241-246. PubMed ID: 31713024
[TBL] [Abstract][Full Text] [Related]
34. Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms.
Badar T; Chlon T
Curr Hematol Malig Rep; 2022 Oct; 17(5):113-120. PubMed ID: 35781188
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and significance of DDX41 gene variants in the general population.
Cheloor Kovilakam S; Gu M; Dunn WG; Marando L; Barcena C; Nik-Zainal S; Mohorianu I; Kar SP; Fabre MA; Quiros PM; Vassiliou GS
Blood; 2023 Oct; 142(14):1185-1192. PubMed ID: 37506341
[TBL] [Abstract][Full Text] [Related]
36. Causative germline variant p.Y259C of DDX41 recurrently identified in acute lymphoblastic leukaemia.
Huo L; Zhang Z; Zhou H; Xie J; Jiang A; Wang Q; Ding Z; Dai H; Liu D; Wu N; Qiu Q; Ma L; Wang M; Wang W; Xue S; Chen Z; Wu D; Yao H; Chen S; Shen H
Br J Haematol; 2023 Jul; 202(1):199-203. PubMed ID: 37144604
[No Abstract] [Full Text] [Related]
37. Are
Xie Z; Starczynowski DT
Haematologica; 2023 Nov; 108(11):2883-2885. PubMed ID: 37317927
[No Abstract] [Full Text] [Related]
38. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Babushok DV; Bessler M; Olson TS
Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Pathologic Spectrum of DDX41-Mutated Hematolymphoid Neoplasms.
Goyal T; Tu ZJ; Wang Z; Cook JR
Am J Clin Pathol; 2021 Oct; 156(5):829-838. PubMed ID: 33929502
[TBL] [Abstract][Full Text] [Related]
40. Germline DDX41 mutant predisposition syndromes: Slow driver states to hematological malignancies.
Chlon TM; Patnaik MM
Am J Hematol; 2023 Nov; 98(11):1673-1676. PubMed ID: 37705260
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
